These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Preventing Staphylococcus aureus bacteremia and sepsis in patients with Staphylococcus aureus colonization of intravascular catheters: a retrospective multicenter study and meta-analysis. Hetem DJ; de Ruiter SC; Buiting AGM; Kluytmans JAJW; Thijsen SF; Vlaminckx BJM; Wintermans RGF; Bonten MJM; Ekkelenkamp MB Medicine (Baltimore); 2011 Jul; 90(4):284-288. PubMed ID: 21694650 [TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine lock solution prevents catheter-associated bacteremia in rabbits. Aslam S; Jenne K; Reed S; Ghannoum M; Mehta R; Darouiche R Int J Artif Organs; 2012 Oct; 35(10):893-7. PubMed ID: 23065881 [TBL] [Abstract][Full Text] [Related]
6. Prolonged antimicrobial activity of a catheter containing chlorhexidine-silver sulfadiazine extends protection against catheter infections in vivo. Bassetti S; Hu J; D'Agostino RB; Sherertz RJ Antimicrob Agents Chemother; 2001 May; 45(5):1535-8. PubMed ID: 11302823 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections. Hampl J; Schierholz J; Jansen B; Aschoff A Acta Neurochir (Wien); 1995; 133(3-4):147-52. PubMed ID: 8748757 [TBL] [Abstract][Full Text] [Related]
8. Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report. Maya ID; Carlton D; Estrada E; Allon M Am J Kidney Dis; 2007 Aug; 50(2):289-95. PubMed ID: 17660030 [TBL] [Abstract][Full Text] [Related]
9. One-step hydrophobization of tannic acid for antibacterial coating on catheters to prevent catheter-associated infections. Liu L; Shi H; Yu H; Zhou R; Yin J; Luan S Biomater Sci; 2019 Dec; 7(12):5035-5043. PubMed ID: 31535105 [TBL] [Abstract][Full Text] [Related]
10. Co-release of dicloxacillin and thioridazine from catheter material containing an interpenetrating polymer network for inhibiting device-associated Staphylococcus aureus infection. Stenger M; Klein K; Grønnemose RB; Klitgaard JK; Kolmos HJ; Lindholt JS; Alm M; Thomsen P; Andersen TE J Control Release; 2016 Nov; 241():125-134. PubMed ID: 27663229 [TBL] [Abstract][Full Text] [Related]
11. Silver iontophoretic catheter: a prototype of a long-term antiinfective vascular access device. Raad I; Hachem R; Zermeno A; Stephens LC; Bodey GP J Infect Dis; 1996 Feb; 173(2):495-8. PubMed ID: 8568321 [TBL] [Abstract][Full Text] [Related]
12. Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters. Sedlacek M; Gemery JM; Cheung AL; Bayer AS; Remillard BD Am J Kidney Dis; 2007 Mar; 49(3):401-8. PubMed ID: 17336701 [TBL] [Abstract][Full Text] [Related]
13. In vivo efficacy of antimicrobial-coated fabric from prosthetic heart valve sewing rings. Darouiche RO; Meade R; Mansouri M; Raad II J Heart Valve Dis; 1998 Nov; 7(6):639-46. PubMed ID: 9870198 [TBL] [Abstract][Full Text] [Related]
14. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881 [TBL] [Abstract][Full Text] [Related]
15. An integrated critique of the efficacy of topical mupirocin in preventing catheter-related Staphylococcus aureus infections in peritoneal dialysis clients. Pratt O CANNT J; 2002; 12(1):20-8. PubMed ID: 11979650 [TBL] [Abstract][Full Text] [Related]
16. A polymer-based anti-quorum catheter coating to challenge MDR Staphylococcus aureus: in vivo and in vitro approaches. Vasudevan S; Durai RD; Chellappan DR; Narayanan VHB; Prabu PC; Solomon AP J Antimicrob Chemother; 2019 Jun; 74(6):1618-1626. PubMed ID: 30863862 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia. Kim SH; Kang CI; Kim HB; Youn SS; Oh MD; Kim EC; Park SY; Kim BK; Choe KW Infect Control Hosp Epidemiol; 2003 Dec; 24(12):897-904. PubMed ID: 14700404 [TBL] [Abstract][Full Text] [Related]
18. Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization. Shah A; Mond J; Walsh S Antimicrob Agents Chemother; 2004 Jul; 48(7):2704-7. PubMed ID: 15215130 [TBL] [Abstract][Full Text] [Related]
19. Bacteremic complications of intravascular catheters colonized with Staphylococcus aureus. Ekkelenkamp MB; van der Bruggen T; van de Vijver DA; Wolfs TF; Bonten MJ Clin Infect Dis; 2008 Jan; 46(1):114-8. PubMed ID: 18171225 [TBL] [Abstract][Full Text] [Related]
20. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis. Walder B; Pittet D; Tramèr MR Infect Control Hosp Epidemiol; 2002 Dec; 23(12):748-56. PubMed ID: 12517018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]